IMCR
Immunocore Holdings Plc
NASDAQ · Healthcare · Biotechnology · GB
$31.27
−4.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.84x
- Price / sales
- 3.99x
- Price / cash flow
- -28.58x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.89x
- EV / EBITDA
- 70.92x
- EV / EBIT
- -66.65x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026